Plasma Glucose and Serum Ceruloplasmin in Metabolic Syndrome and Diabetes Mellitus Type 2
Diabetes mellitus type 2 and metabolic syndrome are conditions associated with insulin resistance and hyperglycemia. Metabolic syndrome is a risk factor for diabetes mellitus type 2. Plasma glucose (fasting/postprandial) and serum ceruloplasmin levels and their relationship were studied. Study popul...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
HATASO
2016-04-01
|
Series: | Recent Advances in Biology and Medicine |
Subjects: | |
Online Access: | https://rabm.scholasticahq.com/article/651-plasma-glucose-and-serum-ceruloplasmin-in-metabolic-syndrome-and-diabetes-mellitus-type-2 |
id |
doaj-3d107b4de59a4f0d94ab5dab46401dbf |
---|---|
record_format |
Article |
spelling |
doaj-3d107b4de59a4f0d94ab5dab46401dbf2020-11-25T00:02:24ZengHATASORecent Advances in Biology and Medicine2378-654X2378-654X2016-04-01220161519dx.doi.org/10.18639/RABM.2016.02.282945282945Plasma Glucose and Serum Ceruloplasmin in Metabolic Syndrome and Diabetes Mellitus Type 2Ashok Kumar Jeppu0Asha Augusthy1Kavitha Ashok Kumar2Biochemistry Unit, International Medical School, Management and Science University, Shah Alam, Selangor, Darul Ehsan, Malaysia.Department of Biochemistry, Sree Narayana Institute of Medical Sciences, Chalakka, North Kuthivathodu P.O., Ernakulam District, Kerala 683594, India.Otolaryngology Unit, International Medical School, Management and Science University, Shah Alam, Selangor, Darul Ehsan, Malaysia.Diabetes mellitus type 2 and metabolic syndrome are conditions associated with insulin resistance and hyperglycemia. Metabolic syndrome is a risk factor for diabetes mellitus type 2. Plasma glucose (fasting/postprandial) and serum ceruloplasmin levels and their relationship were studied. Study population consisted of 150 individuals—50 individuals with diabetes mellitus type 2, 50 individuals with metabolic syndrome, and 50 age- and sex-matched healthy controls. Plasma levels of fasting and postprandial glucose were measured along with serum ceruloplasmin. Data was analyzed by ANOVA and Pearson correlation. The fasting and postprandial plasma glucose levels in metabolic syndrome and diabetes mellitus type 2 were increased when compared to control. Serum ceruloplasmin level was 327.8 ± 68.9 in control, 227.3 ± 46.8 in metabolic syndrome, and 194.0 ± 49.6 in diabetes mellitus type 2 individuals. There was a statistically significant negative correlation between the fasting, postprandial plasma glucose, and serum ceruloplasmin in type 2 diabetes mellitus.https://rabm.scholasticahq.com/article/651-plasma-glucose-and-serum-ceruloplasmin-in-metabolic-syndrome-and-diabetes-mellitus-type-2Diabetes mellitusMetabolic syndromeCeruloplasminGlucose |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ashok Kumar Jeppu Asha Augusthy Kavitha Ashok Kumar |
spellingShingle |
Ashok Kumar Jeppu Asha Augusthy Kavitha Ashok Kumar Plasma Glucose and Serum Ceruloplasmin in Metabolic Syndrome and Diabetes Mellitus Type 2 Recent Advances in Biology and Medicine Diabetes mellitus Metabolic syndrome Ceruloplasmin Glucose |
author_facet |
Ashok Kumar Jeppu Asha Augusthy Kavitha Ashok Kumar |
author_sort |
Ashok Kumar Jeppu |
title |
Plasma Glucose and Serum Ceruloplasmin in Metabolic Syndrome and Diabetes Mellitus Type 2 |
title_short |
Plasma Glucose and Serum Ceruloplasmin in Metabolic Syndrome and Diabetes Mellitus Type 2 |
title_full |
Plasma Glucose and Serum Ceruloplasmin in Metabolic Syndrome and Diabetes Mellitus Type 2 |
title_fullStr |
Plasma Glucose and Serum Ceruloplasmin in Metabolic Syndrome and Diabetes Mellitus Type 2 |
title_full_unstemmed |
Plasma Glucose and Serum Ceruloplasmin in Metabolic Syndrome and Diabetes Mellitus Type 2 |
title_sort |
plasma glucose and serum ceruloplasmin in metabolic syndrome and diabetes mellitus type 2 |
publisher |
HATASO |
series |
Recent Advances in Biology and Medicine |
issn |
2378-654X 2378-654X |
publishDate |
2016-04-01 |
description |
Diabetes mellitus type 2 and metabolic syndrome are conditions associated with insulin resistance and hyperglycemia. Metabolic syndrome is a risk factor for diabetes mellitus type 2. Plasma glucose (fasting/postprandial) and serum ceruloplasmin levels and their relationship were studied. Study population consisted of 150 individuals—50 individuals with diabetes mellitus type 2, 50 individuals with metabolic syndrome, and 50 age- and sex-matched healthy controls. Plasma levels of fasting and postprandial glucose were measured along with serum ceruloplasmin. Data was analyzed by ANOVA and Pearson correlation. The fasting and postprandial plasma glucose levels in metabolic syndrome and diabetes mellitus type 2 were increased when compared to control. Serum ceruloplasmin level was 327.8 ± 68.9 in control, 227.3 ± 46.8 in metabolic syndrome, and 194.0 ± 49.6 in diabetes mellitus type 2 individuals. There was a statistically significant negative correlation between the fasting, postprandial plasma glucose, and serum ceruloplasmin in type 2 diabetes mellitus. |
topic |
Diabetes mellitus Metabolic syndrome Ceruloplasmin Glucose |
url |
https://rabm.scholasticahq.com/article/651-plasma-glucose-and-serum-ceruloplasmin-in-metabolic-syndrome-and-diabetes-mellitus-type-2 |
work_keys_str_mv |
AT ashokkumarjeppu plasmaglucoseandserumceruloplasmininmetabolicsyndromeanddiabetesmellitustype2 AT ashaaugusthy plasmaglucoseandserumceruloplasmininmetabolicsyndromeanddiabetesmellitustype2 AT kavithaashokkumar plasmaglucoseandserumceruloplasmininmetabolicsyndromeanddiabetesmellitustype2 |
_version_ |
1725437956801429504 |